Skip to main content

Axcelis Technologies, Inc.

corporate_fare Company Profile

Axcelis Technologies, Inc.

ACLS·NASDAQ·Technology·CIK 0001113232

Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. The company sells its products to leading semiconductor chip manufacturers globally. Its primary product line is the Purion family of products, which are ion implanters. The ion implantation business accounted for 98.2% of Axcelis' revenue in 2025. The remaining 1.8% of revenue came from aftermarket sales related to other legacy processing systems. Beyond equipment sales, Axcelis provides a range of aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Axcelis' business began in 1978, and its current corporate entity was incorporated in Delaware in 1995. The company is headquartered in Beverly, Massachusetts. In 2025, Axcelis reported total revenue of $839.0 million, down from $1,017.9 million in 2024. Systems revenue specifically was $571.0 million in 2025, compared to $782.6 million in 2024. The gross margin percentage for 2025 was 44.9%, a slight increase from 44.7% in 2024. Operating profit for 2025 was $119.3 million, compared to $210.8 million in 2024. Net income in 2025 was $120.2 million, compared to $201.0 million in 2024.

Axcelis Technologies, Inc. (NASDAQ:ACLS) is a publicly traded company in the Technology sector. Wiseek has independently scored 20 items for ACLS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 11 rated 8 or above. Recent SEC coverage for ACLS spans 8-K, 10-Q, 425, DEF 14A.

Recent high-impact activity:

  • Axcelis Q3 EPS $1.21 Beats Year-Ago $0.83; Q4 Revenue Guided to ~$275M
  • Axcelis Posts 3Q EPS of $1.21
  • Axcelis-Veeco Merger Closing Pushed to End of Q1 2027 on New HSR Filing
  • Axcelis Reports Significant Profitability Decline in Q2 2026; Gross Margin and EPS Fall Year-Over-Year
  • Axcelis Q2 Revenue Tops Forecasts, Q3 Guidance Exceeds Consensus; Veeco Merger Proceeds as Planned

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$839.05M
Net Income
$120.24M
Diluted EPS
$3.80
Op. Cash Flow
$118.31M
Free Cash Flow
$107.01M
Gross Profit
$376.85M
Operating Income
$119.31M
Cash & Equivalents
$145.45M
Debt / Equity
0.00×
Net Margin
14.3%
Shares Outstanding
30.72M sh
Source: 10-K · filed 2026-02-26 · accession 0001104659-26-020461

Short Interest & Short Volume

4.14 days to cover

FINRA reported short interest of 1,347,799 shares in ACLS as of the October 30, 2026 settlement, a 7.0% decrease from the prior period — about 4.1 days to cover at its recent average daily volume. On November 20, 2026, 71.5% of ACLS volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,347,799 shares as of October 30, 2026
Change vs prior period▼ 7.0%
Days to cover4.14 at avg daily volume of 325,682
Daily short volume (FINRA facilities)71.5% of 164,110 shares on November 20, 2026
5-day average short volume72.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with A →
$90.26
52-week range · as of 2026-11-05 $73.6 – $193.78
Market cap
$2.79B
Volume
391.8K (1.0× avg)
3-mo avg 386.7K
Live data · 2026-11-21 20:18 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ACLS - Latest Insights

ACLS
Nov 05, 2026, 8:09 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $99.00
Real-time Price: $90.26 info
Change: -$8.74 (-9%) info
Market Cap: $2.788B info
ACLS
Nov 05, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $94.99
Real-time Price: $90.26 info
Change: -$4.73 (-5%) info
Market Cap: $2.788B info
ACLS
Nov 02, 2026, 8:11 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $101.75
Real-time Price: $90.26 info
Change: -$11.49 (-11%) info
Market Cap: $2.788B info
ACLS
Aug 06, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $136.66
Real-time Price: $90.26 info
Change: -$46.40 (-34%) info
Market Cap: $2.788B info
ACLS
Aug 06, 2026, 8:41 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $144.00
Real-time Price: $90.26 info
Change: -$53.74 (-37%) info
Market Cap: $2.788B info
ACLS
May 08, 2026, 12:21 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $160.56
Real-time Price: $90.26 info
Change: -$70.30 (-44%) info
Market Cap: $2.788B info
ACLS
May 08, 2026, 12:20 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $160.56
Real-time Price: $90.26 info
Change: -$70.30 (-44%) info
Market Cap: $2.788B info
ACLS
May 07, 2026, 4:44 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $153.17
Real-time Price: $90.26 info
Change: -$62.91 (-41%) info
Market Cap: $2.788B info
ACLS
May 07, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $155.67
Real-time Price: $90.26 info
Change: -$65.41 (-42%) info
Market Cap: $2.788B info
ACLS
Apr 29, 2026, 4:15 PM EDT
Filing Type: 425
Importance Score:
7
Price at Filing: $133.59
Real-time Price: $90.26 info
Change: -$43.33 (-32%) info
Market Cap: $2.788B info
ACLS
Mar 31, 2026, 7:28 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $90.43
Real-time Price: $90.26 info
Change: -$0.170 (-0.19%) info
Market Cap: $2.788B info
ACLS
Mar 12, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $85.18
Real-time Price: $90.26 info
Change: +$5.08 (+6%) info
Market Cap: $2.788B info
ACLS
Mar 12, 2026, 4:36 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $85.18
Real-time Price: $90.26 info
Change: +$5.08 (+6%) info
Market Cap: $2.788B info
ACLS
Feb 26, 2026, 3:48 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $83.57
Real-time Price: $90.26 info
Change: +$6.69 (+8%) info
Market Cap: $2.788B info
ACLS
Feb 17, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $85.00
Real-time Price: $90.26 info
Change: +$5.26 (+6%) info
Market Cap: $2.788B info
ACLS
Feb 12, 2026, 5:22 PM EST
Filing Type: 425
Importance Score:
8
Price at Filing: $95.00
Real-time Price: $90.26 info
Change: -$4.74 (-5%) info
Market Cap: $2.788B info
ACLS
Feb 06, 2026, 4:40 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $86.84
Real-time Price: $90.26 info
Change: +$3.42 (+4%) info
Market Cap: $2.788B info
ACLS
Feb 02, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $86.49
Real-time Price: $90.26 info
Change: +$3.77 (+4%) info
Market Cap: $2.788B info
ACLS
Jan 28, 2026, 5:18 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $91.23
Real-time Price: $90.26 info
Change: -$0.970 (-1%) info
Market Cap: $2.788B info
ACLS
Jan 28, 2026, 5:18 PM EST
Filing Type: 425
Importance Score:
8
Price at Filing: $91.23
Real-time Price: $90.26 info
Change: -$0.970 (-1%) info
Market Cap: $2.788B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets